Skip to main content
OpenTrials

Clinical trial condition

Smallpox

Explore clinical trials studying Smallpox. Study availability and eligibility vary by location and protocol.

65 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Smallpox trial results

Completed

Effect of Dose, Safety, Tolerability of a New Smallpox Vaccine in Adults Without Previous Smallpox Vaccination

NCT00053495

Conditions
DNA Virus Infections, Infections, Poxviridae Infections, +2 more
Locations
  • Orlando Clinical Research Center Orlando, Florida, United States
  • PRA International Lenexa, Kansas, United States
  • Bio-Kinetic Clinical Applications Springfield, Missouri, United States
  • Memorial Hospital of Rhode IslandDivision of Infectious Diseases Pawtucket, Rhode Island, United States
View Trial Details
Completed

Study on Immunogenicity, Reactogenicity and Safety of the VACΔ6 Vaccine in Volunteers Aged 18-60 Years

NCT05846243

Conditions
Animal Diseases, Cowpox, DNA Virus Infections, +9 more
Locations
  • Federal State Budgetary Institution of Healthcare "Medical and Sanitary Unit No. 163 of the Federal Medical and Biological Agency" (FGBUZ MSCH-163, FMBA of Russia) Kol'tsovo, Novosibirsk Oblast, Russia
  • State Budgetary Health Institution of the Novosibirsk Region "Municipal Infectious Disease Clinical Hospital No. 1" Novosibirsk, Russia
View Trial Details
Completed

Study to Assess Brincidofovir Treatment of Serious Diseases or Conditions Caused by Double-stranded DNA Viruses

NCT01143181

Conditions
Adenoviridae Infections, DNA Virus Infections, Double-stranded DNA Virus, +11 more
Locations
  • Loma Linda University Hospital Loma Linda, California, United States
  • Children's Hospital of LA Los Angeles, California, United States
  • UCLA Department of Medicine Los Angeles, California, United States
  • CHOC Children's Orange, California, United States
View all 37 locations
View Trial Details
Completed

Freeze-Dried MVA-BN® Lot Consistency Smallpox Trial

NCT03699124

Conditions
DNA Virus Infections, Infections, Poxviridae Infections, +2 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Optimal Research, LLC (Synexus) Melbourne, Florida, United States
  • Optimal Research, LLC (Synexus) Peoria, Illinois, United States
  • University of Iowa Iowa City, Iowa, United States
View Trial Details
Completed

Lyophilized IMVAMUNE® (1x10^8 TCID50) Versus Liquid IMVAMUNE® (1x10^8 TCID50) Administered Subcutaneously and a Lower Dose Liquid IMVAMUNE® (2x10^7 TCID50) Administered Intradermally

NCT00914732

Conditions
DNA Virus Infections, Infections, Poxviridae Infections, +2 more
Locations
  • Emory Vaccine Center - The Hope Clinic Decatur, Georgia, United States
  • University of Iowa - Vaccine Research & Education Unit Iowa City, Iowa, United States
  • University of Maryland School of Medicine - Center for Vaccine Development - Baltimore Baltimore, Maryland, United States
  • Saint Louis University - Center for Vaccine Development St Louis, Missouri, United States
View Trial Details
Completed

Randomized, Open-label Phase II Trial to Assess the Safety and Immunogenicity of MVA-BN Smallpox Vaccine in Immunocompromised Subjects With HIV Infection

NCT02038881

Conditions
DNA Virus Infections, Infections, Poxviridae Infections, +2 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Health for Life Clinic Little Rock Little Rock, Arkansas, United States
  • Quest Clinical Research San Francisco, California, United States
  • Dupont Circle Physicians Group Washington D.C., District of Columbia, United States
View Trial Details

Related conditions